Results indicated that RBM39 expression was significantly elevated in CRC cell lines, particularly in HT29 and RKO cells, at both the mRNA (Fig. 1E) and protein levels (Fig. 1F). This evidence concerns the gene RBM39 and colorectal carcinoma.